(Q27077891)

GSK269962A (English)

3 October 2016

C₂₉H₃₀N₈O₅

1 reference

GSK269962A (English)

3 October 2016

CCN1C2=CC(=NC=C2N=C1C3=NON=C3N)OC4=CC=CC(=C4)NC(=O)C5=CC=C(C=C5)OCCN6CCOCC6

1 reference

InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)

English

title

GSK269962A (English)

retrieved

3 October 2016

Identifiers

InChI

1 reference

GSK269962A (English)

3 October 2016

1 reference

GSK269962A (English)

3 October 2016

0 references

1 reference

English

title

N-(3-{[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy}phenyl)-4-[2-(4-morpholinyl)ethoxy]benzamide (English)

3 October 2016

1 reference

GSK269962A (English)

3 October 2016

1 reference

English

title

GSK-269962A (English)

3 October 2016

2 references

inferred from InChIKey

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

1 reference

2 references

DSSTOX compound identifier

DTXCID40533261

0 references

Guide to Pharmacology Ligand ID

8037

1 reference

stated in

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

8037

GSK269962A (English)

3 October 2016

1 reference

UNII

F89KMM7TE2

1 reference